Retinal Vascular Manifestations in Patients With Common Internal Diseases on Optical Coherence Tomography Angiography

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Hypertension, diabetes mellitus, and dyslipidemia are common internal diseases, and all diseases are atherosclerosis risk factors. Previous studies applied color fundus photography to analyze retinal vascular changes (including exudation, hemorrhage, neovascularization, etc.) in patients with hypertension or diabetes, but the examination results could not be quantified. This study intends to apply optical coherence tomography angiography (OCTA) to examine retinal vessels. This method has the following advantages: 1) It can quantify vascular changes, and 2) It is noninvasive and reproducible for patients' follow-up. This study was designed to investigate retinal vascular changes in patients with hypertension, diabetes, and dyslipidemia on OCTA. We will collect the patients' general information (gender, age), comorbidities, medications, blood lipids, blood glucose, carotid ultrasound, ankle-brachial index, ambulatory blood pressure monitoring, color fundus photography, and OCTA results. We will follow up with the patients for five years and conduct the mentioned examinations once a year. We will also investigate the correlation between systemic atherosclerosis (such as coronary artery stenosis, and carotid artery stenosis) and retinal vasculopathy in patients with these diseases.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with hypertension

• Or patients with diabetes

• Or patients with dyslipidemia

• Agree to participate in this study

Locations
Other Locations
China
Beijing Tongren Hospital
RECRUITING
Beijing
Contact Information
Primary
Yu He, MD
bluelight323@126.com
+861058268320
Backup
Ma Jinbao, MD
majinbao77@sina.com
+861058268320
Time Frame
Start Date: 2022-03-01
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 300
Treatments
Hypertension
No intervention
Diabetes mellitus
No intervention
Dyslipidemia
No intervention
Sponsors
Leads: Beijing Tongren Hospital

This content was sourced from clinicaltrials.gov